Skip to main content

Month: September 2020

Notice of third quarter 2020 results and conference call

Notice of third quarter 2020 results and conference call Luxembourg, September 25, 2020 – Millicom will announce its third quarter results on October 30, 2020 at approximately 11:00 (Stockholm) / 10:00 (London) / 06:00 (Miami) via a press release.The company will host a conference call for the global financial community on October 30, 2020 at 13:00 (Stockholm) / 12:00 (London) / 08:00 (Miami).The conference call will be webcast at millicom.comDial-in information:Please dial in 5-10 minutes before the scheduled start time to register your attendance. Dial-in numbers for the call are as follows:Sweden:          +46 (0) 8566-19361                            Luxembourg:  +352-2786-6996UK:                  +44 (0) 2031-070289                          US:                   +1-914-987-7208The access code is: 4064116Replay information:A replay...

Continue reading

YANGAROO Announces The Launch Of EZ Downloads; Software-Free Secure Watermarked Cloud-Based Downloads

TORONTO, Sept. 25, 2020 (GLOBE NEWSWIRE) — YANGAROO Inc. (“Yangaroo”, “Company”), (TSX-V: YOO, OTCBB: YOOIF), the software leader in workflow management and media distribution solutions, today announced the launch of a major upgrade to its cloud-based Yangaroo Music distribution platform. The Yangaroo Music platform runs on Yangaroo’s DMDS workflow solution for Media and Entertainment companies based entirely in the cloud. DMDS users, including professionals in radio, media and other promotional music outlets, are now able to download new music and accompanying promo assets directly through their web browser with the same efficiency and security as using the existing application interface. This update has been dubbed EZ Downloads and provides a significant market advantage over competing services, making Yangaroo Music and DMDS...

Continue reading

Cabaletta Bio to Present at Upcoming Investor Conferences in October

PHILADELPHIA, Sept. 25, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will present at the following three upcoming investor conferences in October:Stifel 2020 Immunology and Inflammation Virtual Summit: “The Potential for Treg Modifying and CAR T Therapies in Immunology” panel on Thursday, October 1, 2020 at 3:00 p.m. ET.Jefferies Virtual Cell Therapy Summit: Fireside chat on Monday, October 5, 2020 at 8:30 a.m. ET.Chardan 4thAnnual Genetic Medicines Conference: Fireside chat on Tuesday, October 6, 2020 at 11:30 a.m. ET.A live webcast of these presentations will be available...

Continue reading

Graybug Appoints Three New Members to its Board of Directors

REDWOOD CITY, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve, today announced the appointment of three new members to the company’s Board of Directors with immediate effect. Christina Ackermann will chair Graybug’s Nominating and Corporate Governance Committee and serve as a member of its Compensation Committee. Eric Bjerkholt, MBA, will chair the company’s Compensation Committee and serve as a member of the Audit Committee. Julie Eastland, MBA, will chair the Audit Committee.Ms. Ackermann, Mr. Bjerkholt and Ms. Eastland replace Emmett Cunningham, Jr., MD, PhD, Managing Director at Blackstone Lifesciences Group, Chau Q. Khuong, MPH, Partner...

Continue reading

Catalyst Biosciences to Present at the Stifel Immunology and Inflammation Summit

SOUTH SAN FRANCISCO, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse, Ph.D., senior vice president of translational research, will present at the Stifel Immunology and Inflammation Virtual Summit. Dr. Blouse will speak on a panel entitled: “The evolution of complement targeted therapies,” taking place on Thursday, October 1, 2020, at 9:00 AM Eastern Time.To access a live webcast of the panel presentation, please click here.An archived webcast of the presentation will be available for 90 days on the Events and Presentations section on the Company’s website.About Catalyst BiosciencesCatalyst is a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hematologic and complement-mediated disorders. Our protease engineering...

Continue reading

Kratos Awarded $950 Million Multiple-Award, IDIQ Contract for U.S. Air Force Advanced Battle Management System (ABMS)

SAN DIEGO, Sept. 25, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that it has been awarded a $950,000,000 ceiling indefinite-delivery/indefinite-quantity contract for the maturation, demonstration and proliferation of capability across platforms and domains, leveraging open systems design, modern software and algorithm development in order to enable Joint All Domain Command and Control (JADC2). This contract is part of a multiple award multi-level security effort to provide development and operation of systems as a unified force across all domains (air, land, sea, space, cyber, and electromagnetic spectrum) in an open architecture family of systems that enables capabilities via multiple integrated platforms.Kratos offers solutions...

Continue reading

Rogers announces comprehensive $3 billion investment proposal to benefit Quebec

Rogers unveils investments to honour Cogeco’s legacy, expand rural connectivity, accelerate 5G coverage to 95% of Quebecers and create hundreds of highly skilled jobs with new tech innovation hubMONTREAL and TORONTO, Sept. 25, 2020 (GLOBE NEWSWIRE) — After 35 years of building in Quebec, Rogers today unveiled a $3 billion investment proposal to bring connectivity, jobs and economic growth to Quebec should it be successful in its bid to acquire Cogeco’s Canadian assets.“Rogers is deeply committed to the future of innovation and the knowledge economy in Quebec. We would be honoured to help enhance the customer experience and bring new investments including 5G that will fundamentally reshape the economic landscape of Quebec,” said Joe Natale, President and CEO, Rogers Communications. “This is about the future, and helping ensure that...

Continue reading

Bombardier celebrates unveiling of train design for India’s first semi-high-speed RRTS corridor

India’s first Regional Rapid Transit System (RRTS) will operate one of the fastest trains in India with a design speed of 180 kilometers per hour reducing travel time between Meerut and Delhi to less than 60 minutesSleek modern train design is inspired by Delhi’s iconic monument The Lotus TempleBERLIN, Sept. 25, 2020 (GLOBE NEWSWIRE) —Note to editors: To view the photo and the PDF document associated with this press release, please visit the following links:Today, global mobility technology leader Bombardier Transportation and India’s National Capital Region Transport Corporation (NCRTC) celebrated the unveiling of train design for India’s first Regional Rapid Transit System (RRTS). The train design was unveiled by Durga Shanker Mishra, Secretary, Ministry of Housing and Urban Affairs, Government of India in the presence of Vinay...

Continue reading

Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics

NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Sept. 25, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into an implementation and equipment financing partnership with AID Genomics, a multi-national genomic R&D company and solution provider focusing on precision medicines for cancers and infectious diseases. AID Genomics recently completed a contract with the Ministry of Health in Israel to build and scale-up 6 HMO laboratories in Israel. In addition, AID Genomics has entered into a worldwide partnership with Tecan Group for delivery of liquid handler machines....

Continue reading

Weyland Tech Begins Trading Under New Company Name, Logiq, and Ticker Symbol, LGIQ

NEW YORK, Sept. 25, 2020 (GLOBE NEWSWIRE) — Logiq, Inc. (formerly Weyland Tech) (OTCQX: WEYL) (OTCQX:LGIQ), a global provider of award-winning eCommerce solutions, has received notification from the Financial Industry Regulatory Authority (FINRA) that its new name, Logiq, Inc., would take effect on the over-the-counter market on September 25, 2020. At the open of trading today, on September 25, 2020, the company commenced trading of its common stock under the new name, Logiq, Inc., and its ticker symbol changed from “WEYL” to “LGIQ.”“Our new name and ticker reflects our evolution from operating primarily as a mCommerce services company to becoming a leading innovator of data-driven consumer intelligence and marketing technology,” said Logiq CEO, Tom Furukawa. “We’ve now entered a new stage of accelerated growth and development.”Over...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.